Distal myocardial protection during percutaneous coronary intervention with an intracoronary β-blocker

Circulation

Volumn 107, Issue 23, 2003, Pages 2914-2919

  Wei Wang, Fen ^b   Osman, Abdulfatah ^b   Otero, Javier ^b   Stouffer, George A ^b   Waxman, Sergio ^b   Afzal, Adrian ^b   Anzuini, Angelo ^b   Uretsky, Barry F ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

Angioplasty; Beta blockers, adrenergic; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; PROPRANOLOL; TROPONIN T;

ADULT; AGED; ARTERY CATHETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEART PROTECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE; CREATINE KINASE, MB FORM; DOUBLE-BLIND METHOD; FEMALE; HEART; HUMANS; INJECTIONS, INTRA-ARTERIAL; ISOENZYMES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPRANOLOL; RISK; SAMPLE SIZE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0038311040     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000072787.25131.03     Document Type: Article

References (27)

1. Oh JK, Shub C, Ilstrup DM, et al. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985;109:1225-1231.
2. Simoons ML, Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J. 1999;20:1112-1119.
3. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 1996;94:1528-1536.
4. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002;105:554-556.
5. Ellis SG, Chew D, Chan A, et al. Death following creatine kinase-MB elevation after coronary intervention. Circulation. 2002;106:1205-1210.
6. Topol EJ, Yadav JS. Recognition of importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-580.
7. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusion. Circulation. 1971;43:67-82.
8. Reimer KA, Rasmussen MM, Jennings RB. Reduction by propranolol of myocardial necrosis following temporary coronary occlusion in dogs. Circ Res. 1973;33:353-363.
9. Reimer KA, Rasmussen MM, Jennings RB. On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs. Am J Cardiol. 1976;37:520-527.
10. Miura M, Thomas R, Ganz W, et al. The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation. 1979;59:1148-1157.
11. Gold HK, Leinbach RC, Maroko PR. Regional blockade with intracoronary propranolol. Circulation. 1976;54(suppl II):II-173. Abstract.
12. Zalewski A, Goldberg S, Dervan JP, et al. Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional beta-adrenergic blockade. Circulation. 1986;73:734-739.
13. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 2000;21:1502-1513.
14. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
15. Fox K, Welman E, Selwyn A. Myocardial infarction in the dog: effects of intravenous propranolol. Am J Cardiol. 1983;45:769-774.
16. Torr S, Drake-Holland AJ, Main M, et al. Effects on infarct size of reperfusion and pretreatment with β-blockade and calcium antagonists. Basic Res Cardiol. 1989;84:564-582.
17. Peter T, Norris RM, Clarke ED, et al. Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation. 1978;57:1091-1095.
18. Boyle DM, Barber JM, McIlmoyle EL, et al. Effect of very early intervention with metoprolol on myocardial infarct size. Br Heart J. 1983;49:229-233.
19. Roberts R, Croft C, Gold HR, et al. Effect of propranolol on myocardialinfarct size in a randomized blinded multicenter trial. N Engl J Med. 1984;311:218-225.
20. The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med. 1984;310:9-15.
21. Abdelmeguid AE, Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 1996;131:1097-1105.
22. Blankenship JC, Tasissa G, O'Shea JC, et al. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J Am Coll Cardiol. 2001;38:653-658.
23. Feldman RL, Macdonald RG, Hill JA, et al. Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion. Circulation. 1986;73:727-733.
24. Labovitz AJ, Barth C, Castello R, et al. Attenuation of myocardial ischemia during coronary occlusion by ultrashort-acting beta adrenergic blockade. Am Heart J. 1991;121:1347-1352.
25. Sharma SK, Kini A, Marmur JD, et al. Cardioprotective effect of prior β-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention. Circulation. 2000;102:166-172.
26. Ellis SG, Brener SJ, Lincoff M, et al. β-Blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation. 2001;104:2685-2688.
27. 2002 Heart and Stroke Statistical Update. Biostatistical Fact Sheet; Miscellaneous: Cardiovascular Procedure. American Heart Association Web site. Available at: http://www.americanheart.org/downloadable/heart/ 104575420599FS18CVP3.pdf. Accessed May 15, 2003.